A retrospective study of efficacy of nivolumab, pembrolizumab and atezolizumab in lung cancer patients
Latest Information Update: 14 Jul 2021
At a glance
- Drugs Atezolizumab (Primary) ; Nivolumab (Primary) ; Pembrolizumab (Primary)
- Indications Adenocarcinoma; Lung cancer; Squamous cell cancer
- Focus Therapeutic Use
- 14 Jul 2021 New trial record
- 01 Jul 2021 Results published in the Anticancer Research